American Injectables, a Florida-based contract development and manufacturing organisation (CDMO) specialising in sterile injectables, announced on Thursday that it has received US Food and Drug Administration (FDA) approval, ensuring that its injectables meet the stringent regulatory standards needed for patient safety and efficacy.
FDA approval positions American Injectables as a trusted partner for pharmaceutical companies seeking scalable and compliant sterile injectable solutions, the company said.
"Receiving FDA approval not only validates the strength of our manufacturing processes and our team's dedication to quality but also reinforces our commitment to our clients," said Travis Allen, interim CEO of American Injectables. "It enables them to bring life-saving therapies to market faster and with greater confidence."
Lundbeck receives FDA Fast Track designation for amlenetug in multiple system atrophy
Moleculin's Phase 3 R/R AML pivotal trial receives first European country recruitment approval
Biohaven secures FDA priority review for troriluzole in spinocerebellar ataxia
Owens & Minor launches ByramConnect digital health platform for diabetes management
Novartis to acquire Anthos Therapeutics in USD925m deal to expand cardiovascular pipeline
bioMérieux secures US FDA clearance for new gastrointestinal diagnostic panel
EssilorLuxottica expands med-tech portfolio with Cellview acquisition
Axsome Therapeutics settles patent litigation with Teva over AUVELITY
Hemab Therapeutics reveals interim data from ongoing HMB-001 phase two study
AbbVie's EMBLAVEO receives US FDA approval for complicated intra-abdominal infections
Eton Pharmaceuticals secures US patent for ET-600, protecting formulation through 2044
Lilly's Omvoh shows sustained efficacy in Crohn's disease after two years
Bio-Thera Solutions secures EMA acceptance for BAT2506 biosimilar application
BioArctic reports strong royalty growth from Leqembi sales in Q4 2024